unfortunately the only news that shows there will be a traction is if sales make the company money. the problem is that this type of ramp up period will not be something that every doctor across the nation will be telling each other to use adasuve. One major reason is the REMS.
So we have an contradicting situation here where the street will only get a positive article on Adasuve if sales drive ALXA to profitability where someone can talk about the drug working wonders. This is not like the cure for cancer or the cure for HIV where the drug miracle will speak for itself. I do believe in their own niche it will do its job and outsell other solutions. But again there are many headwinds that ALXA must overcome.
Frankly they have a myopia for some time that they get caught up between selling one drug to keep the company alive, when reality they should be selling the platform across the board.
Look at Antares, they do the same thing for injections, they trade at a $500mm market cap, vs our sub 100mm market cap. BTW, why is Aradigm ARDM trading at a higher valuation than us, yet they have no drugs on the market.
thanks for the comments and reply. I do agree with most of your points, however, we cannot deny that ALXA needs to do a better job at shareholder communication and relations.
For the reasons you mentioned, I am here for the long term and do believe this will be a success one way or another. How it transfers to us as shareholders is still a mystery.
However, with regards to the day to day fluctuations, one of the primary reasons good shareholder communication is needed is to get more liquidity in the stock for people to get in and out of it as a needed basis.
For instance, if I get margin calls for instance in another position, because ALXA is not marginable, it would be one of the first I may need to sell because it reduces buying power by 50%. If ALXA cares as people like me to hold their stock and get their most value of it, they would be more concerned to give new and interested shareholders the proper information to make their investment decision. Basically you have done most of their job which is why I was asking why you were their #1 cheerleader, although you care to properly inform others, it borders also giving misinformation because the company doesn't confirm most of the details in their own pr's. Because you are heavily vested, rather than show management your kind support and positive attitude, perhaps it is time you start complaining to them since you have the closest direct line to King here vs a lot of us here do. Based on your seekingalpha posts, it shows you had a method to get his attention to answer your questions.
actually he/she has a point. Why aren't we hearing these things from the company. Even other penny stock biotechs mention when they file patents to communicate it to shareholders what they're doing. This company sounds like they want to take us for a ride without telling us where we're going.
If anything the narcissist running the company feels their approval ratings are high because someone like ATLnsider keeps posting these things. It is like how Obama believes in his own bs.
I believe they will have at least 45k units shipped this quarter. My estimation is TEVA got a batch of 10k end of Sept, and began a rate of 10k per month to handle stocking plus replenishment as they turn over.
I will be happy if they even get 10 on this platform. I've lowered my long term projection this can be a $5bb company to $1bb. I have discounted their incompetence to lower the potential this current team has vs if a Musk ran it.
my problem is that the drug may sell, but the company may not capitalize on the opportunity. I am hoping this guy does have integrity to do what is right.
If a company is a good company, and has good products, and they continue to innovate off them, it will be good. RIMM was not good at innovating after blackberry email, so look where they are now. Plug is good both last year and this year, IMHO it will continue to go higher in the mid term.
TSLA may be good it may not going forward if cars go to fuel cell. The batt will be dead. Personally I think so.
I always trust and verify.
You are correct, but at the same time, the stock should go up as the prospects of making more money, revenue or taking market share increases. I don't need to know that companies like TSLA or CRM continually experience share price increases because they focus more on growing the company's dominance in their field of expertise and target markets.
ALXA is supposed to be doing this, those of us like myself that believe they are doing it continue to support the company, but like I said, the company does nothing to gain further support which would reflect in increased liquidity and share price strength. I have shares in PLUG which is probably was further from making money than ALXA, but you can see how the shareprice has indicated people have more faith in it than ALXA.
I wasn't sleeping. just frustrated why we haven't heard anything. As I said before a great product will eventually lead to sales and profit. MSFT with ballmer didn't do as good as gates, but nonetheless still was making MSFT money.
honestly atlnsider, you have been giving much more information than ALEXZA has been giving its shareholders. This is frustrating to say the least that ALXA obviously does NOT care about its common shareholders. You can see this as the stock languishes in a unguided direction.
ALXA does not give the analyst enough information to make an accurate determination of headwinds for their product, and only gives optimistic viewpoints based on comments as forward looking statements which are protected by the disclaimer every company uses to protect themselves from shareholder lawsuits. The reason they do not want to stick their neck out is probably true because they place themselves first before common shareholders, who are their owners who are their bosses.
We still have yet to hear precisely their plans for funding AZ-002 in the pipeline, and I'm not to say I believe it is from the form of dilution, but if in fact they have a partner coming, why do not they say upfront we are in discussions. They like to keep people in the dark for the sake of their own interests.
gates is largest shareholder of deere. he's been buying lately.
2013 didn't add up to 30mm a year. It was only around $15mm, and cost of goods increasing is not a bad sign as that means they are selling product. it's nice to see R&D and G&A drop. Opex does seem rather high.
unfortunately we need a deal to be announced before revenue off sales will get to the level where we can cover expenses. I have asked several times, why we burn $30mm a year when there is no clinical trials. Is the rent on their building $5mm a year or what?
No doubt this has been a dog, I will take profits in DE as they come (perhaps more than just the dividends) If I end up doubling down on the hot knife I will do it.